Daniel Epshtein
Optometrist · Brooklyn, NYNPI 1750763769
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Carl Zeiss Meditec, Inc. at 37.5% of the total. Among optometrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $327.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$16K
- Tarsus Pharmaceuticals, Inc.$15K
- AbbVie$3K
- Amgen$1K
- Regeneron$1K
- Oyster Point Pharma, Inc.$1K
- plus $5K from 15 others
What the payments were for
- Consulting fees$9,44622%
- Speaking & faculty fees$23,31155%
- Travel & lodging$2,1945%
- Food & beverage$7,50618%
- Education$40%
- Gifts$560%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 37 | $15,958 |
| Tarsus Pharmaceuticals, Inc. | 24 | $15,419 |
| AbbVie(2 entities) | 16 | $2,936 |
| Amgen | 6 | $1,306 |
| Regeneron | 6 | $1,264 |
| Oyster Point Pharma, Inc. | 6 | $1,017 |
| Apellis Pharmaceuticals, Inc. | 2 | $911 |
| Immunogen, Inc. | 2 | $817 |
| Novartis | 5 | $569 |
| Bausch & Lomb Americas Inc. | 5 | $512 |
| Aerie Pharmaceuticals, Inc. | 4 | $484 |
| Alcon | 5 | $382 |
| Astellas Pharma US Inc | 2 | $226 |
| Topcon Healthcare, Inc. | 2 | $187 |
| Glaukos Corporation | 1 | $132 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $118 |
| Harrow Eye, LLC | 1 | $99 |
| Astellas Pharma Global Development | 1 | $61 |
| Kala Pharmaceuticals, Inc. | 1 | $52 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Sight Sciences, Inc. | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FORUM$10,875
- CIRRUS HD-OCT$10,167
- XDEMVY$9,116
- Humphrey HFA$8,513
- CLARUS$7,696
- CLARUS 500 Fundus Camera$4,500
- VisuMax$3,167
- Glaucoma Workplace$1,250
- VUITY$1,198
- LUMIGAN$1,149
- TEPEZZA$1,110
- EYLEA$1,078
- FORUM Glaucoma Workplace$1,050
- Retina Workplace$1,050
- TYRVAYA$847
- Elahere$817
- DURYSTA$750
- XEN GLAUCOMA TREATMENT SYSTEM$750
- Humphrey Field Analyzer (HFA3)$700
- Rhopressa$609
How this compares
$42,517 in reported general payments places this provider in the 95th percentile of 2,743 optometrist providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 175 | $114,889 |
| XiidraLifitegrast | 56 | $42,521 |
| Cyclosporine | 23 | $5,148 |
| Brimonidine Tartrate | 28 | $3,172 |
| Azelastine Hcl | 185 | $2,889 |
| Latanoprost | 389 | $2,169 |
| Travoprost | 14 | $752 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 41 | $609 |
| Dorzolamide Hcl | 16 | $242 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $2,936 | $114,889175 claims |
| Bausch & Lomb Americas Inc.Xiidra | $512 | $42,52156 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,743 optometrist providers in New York.
Other optometrist in Brooklyn
- Justin BazanBrooklyn$303K
- Katherine MastrotaBrooklyn$14K
- Roy KlineLake Katrine$822K
- Susan ResnickNew York$463K
- Murray FingeretHewlett$374K
- Albert MorierSlingerlands$347K
- Denise WhittamNew York$343K
- Jennifer TsaiNew York$275K
- Alexander KabiriQueens Village$268K
- Sophia VisanjiNew York$233K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.